|
1
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 world health organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Forst DA, Nahed BV, Loeffler JS and
Batchelor TT: Low-grade gliomas. Oncologist. 19:403–413. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Groot JF: High-grade gliomas. Continuum
(Minneap Minn. ). 21:332–344. 2015.PubMed/NCBI
|
|
4
|
Kim IA, Yang YJ, Yoon SC, Choi IB, Kay CS,
Kwon HC, Kim CM, Joe YA, Kang JK and Hong YK: Potential of
adenoviral p53 gene therapy and irradiation for the treatment of
malignant gliomas. Int J Oncol. 19:1041–1047. 2001.PubMed/NCBI
|
|
5
|
Maris D, Nica D, Mohan D, Moisa H and
Ciurea AV: Multidisciplinary management of adult low grade gliomas.
Chirurgia (Bucur). 109:590–599. 2014.PubMed/NCBI
|
|
6
|
Pekmezci M and Perry A: Genetic markers in
adult high-grade gliomas. Semin Radiat Oncol. 24:235–239. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Duffy A, Le J, Sausville E and Emadi A:
Autophagy modulation: A target for cancer treatment development.
Cancer Chemother Pharmacol. 75:439–447. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin Q, Mao KL, Tian FR, Yang JJ, Chen PP,
Xu J, Fan ZL, Zhao YP, Li WF, Zheng L, et al: Brain tumor-targeted
delivery and therapy by focused ultrasound introduced
doxorubicin-loaded cationic liposomes. Cancer Chemother Pharmacol.
77:269–280. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bennett EP, Hassan H, Hollingsworth MA and
Clausen H: A novel human UDP-N-acetyl-D-galactosamine: Polypeptide
N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for
partial GalNAc-glycosylated acceptor substrates. FEBS Lett.
460:226–230. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu H, Chen J, Li D, Liu X, Li L and Wang
K: MicroRNA-30e functions as a tumor suppressor in cervical
carcinoma cells through targeting GALNT7. Transl Oncol. 10:876–885.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu Q, Xu L, Li C, Yuan Y, Huang S and Chen
H: miR-214 inhibits invasion and migration via downregulating
GALNT7 in esophageal squamous cell cancer. Tumour Biol.
37:14605–14614. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shan SW, Fang L, Shatseva T, Rutnam ZJ,
Yang X, Du W, Lu WY, Xuan JW, Deng Z and Yang BB: Mature miR-17-5p
and passenger miR-17-3p induce hepatocellular carcinoma by
targeting PTEN, GalNT7 and vimentin in different signal pathways. J
Cell Sci. 126:1517–1530. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Y, Li Y, Chen D, Jin L, Su Z, Liu J,
Duan H, Li X, Qi Z, Shi M, et al: miR30a5p in the tumorigenesis of
renal cell carcinoma: A tumor suppressive microRNA. Mol Med Rep.
13:4085–4094. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Duan HF, Li XQ, Hu HY, Li YC, Cai Z, Mei
XS, Yu P, Nie LP, Zhang W, Yu ZD and Nie GH: Functional elucidation
of miR-494 in the tumorigenesis of nasopharyngeal carcinoma. Tumour
Biol. 36:6679–6689. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li W, Ma H and Sun J: MicroRNA34a/c
function as tumor suppressors in Hep2 laryngeal carcinoma cells and
may reduce GALNT7 expression. Mol Med Rep. 9:1293–1298. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gaziel-Sovran A, Segura MF, Di Micco R,
Collins MK, Hanniford D, de Miera Vega-Saenz E, Rakus JF, Dankert
JF, Shang S, Kerbel RS, et al: miR-30b/30d regulation of GalNAc
transferases enhances invasion and immunosuppression during
metastasis. Cancer Cell. 20:104–118. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mayer A, Schneider F, Vaupel P, Sommer C
and Schmidberger H: Differential expression of HIF-1 in
glioblastoma multiforme and anaplastic astrocytoma. Int J Oncol.
41:1260–1270. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gonda DD, Cheung VJ, Muller KA, Goyal A,
Carter BS and Chen CC: The cancer genome atlas expression profiles
of low-grade gliomas. Neurosurg Focus. 36:E232014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
The Genotype-Tissue Expression (GTEx)
project. Nat Genet. 45:580–585. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Du J, Yuan Z, Ma Z, Song J, Xie X and Chen
Y: KEGG-PATH: Kyoto encyclopedia of genes and genomes-based pathway
analysis using a path analysis model. Mol Biosyst. 10:2441–2447.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pouleau HB, Sadeghi N, Baleriaux D, Melot
C, De Witte O and Lefranc F: High levels of cellular proliferation
predict pseudoprogression in glioblastoma patients. Int J Oncol.
40:923–928. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsuda M and Tanaka S: Roles for crk in
cancer metastasis and invasion. Genes Cancer. 3:334–340. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yukinaga H, Shionyu C, Hirata E, Ui-Tei K,
Nagashima T, Kondo S, Okada-Hatakeyama M, Naoki H and Matsuda M:
Fluctuation of Rac1 activity is associated with the phenotypic and
transcriptional heterogeneity of glioma cells. J Cell Sci.
127:1805–1815. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Priester M, Copanaki E, Vafaizadeh V,
Hensel S, Bernreuther C, Glatzel M, Seifert V, Groner B, Kögel D
and Weissenberger J: STAT3 silencing inhibits glioma single cell
infiltration and tumor growth. Neuro Oncol. 15:840–852. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chandramohan V, Bryant JD, Piao H, Keir
ST, Lipp ES, Lefaivre M, Perkinson K, Bigner DD, Gromeier M and
McLendon RE: Validation of an Immunohistochemistry Assay for
Detection of CD155, the poliovirus receptor, in malignant gliomas.
Arch Pathol Lab Med. 141:1697–1704. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xia S, Lal B, Tung B, Wang S, Goodwin CR
and Laterra J: Tumor microenvironment tenascin-C promotes
glioblastoma invasion and negatively regulates tumor proliferation.
Neuro Oncol. 18:507–517. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Brosicke N, van Landeghem FK, Scheffler B
and Faissner A: Tenascin-C is expressed by human glioma in vivo and
shows a strong association with tumor blood vessels. Cell Tissue
Res. 354:409–430. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Machado CM, Freitas AT and Couto FM:
Enrichment analysis applied to disease prognosis. J Biomed
Semantics. 4:212013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mueller C, deCarvalho AC, Mikkelsen T,
Lehman NL, Calvert V, Espina V, Liotta LA and Petricoin EF III:
Glioblastoma cell enrichment is critical for analysis of
phosphorylated drug targets and proteomic-genomic correlations.
Cancer Res. 74:818–828. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hou M, Liu X, Cao J and Chen B: SEPT7
overexpression inhibits glioma cell migration by targeting the
actin cytoskeleton pathway. Oncol Rep. 35:2003–2010. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Klopocka W, Korczynski J and Pomorski P:
Cytoskeleton and nucleotide signaling in glioma C6 cells. Adv Exp
Med Biol. 986:103–119. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Uzdensky A, Kristiansen B, Moan J and
Juzeniene A: Dynamics of signaling, cytoskeleton and cell cycle
regulation proteins in glioblastoma cells after sub-lethal
photodynamic treatment: Antibody microarray study. Biochim Biophys
Acta. 1820:795–803. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang BY, Zhan YP, Zong WJ, Yu CJ, Li JF,
Qu YM and Han S: The PD-1/B7-H1 pathway modulates the natural
killer cells versus mouse glioma stem cells. PLoS One.
10:e01347152015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Miller JS: Biology of natural killer cells
in cancer and infection. Cancer Invest. 20:405–419. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
He W, Kuang Y, Xing X, Simpson RJ, Huang
H, Yang T, Chen J, Yang L, Liu E, He W and Gu J: Proteomic
comparison of 3D and 2D glioma models reveals increased HLA-E
expression in 3D models is associated with resistance to NK
cell-mediated cytotoxicity. J Proteome Res. 13:2272–2281. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Orozco-Morales M, Sanchez-Garcia FJ,
Golan-Cancela I, Hernández-Pedro N, Costoya JA, de la Cruz VP,
Moreno-Jiménez S, Sotelo J and Pineda B: RB mutation and RAS
overexpression induce resistance to NK cell-mediated cytotoxicity
in glioma cells. Cancer Cell Int. 15:572015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mainiero F, Soriani A, Strippoli R,
Jacobelli J, Gismondi A, Piccoli M, Frati L and Santoni A: RAC1/P38
MAPK signaling pathway controls beta1 integrin-induced
interleukin-8 production in human natural killer cells. Immunity.
12:7–16. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Billadeau DD, Brumbaugh KM, Dick CJ,
Schoon RA, Bustelo XR and Leibson PJ: The Vav-Rac1 pathway in
cytotoxic lymphocytes regulates the generation of cell-mediated
killing. J Exp Med. 188:549–559. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nicolas CS, Amici M, Bortolotto ZA,
Doherty A, Csaba Z, Fafouri A, Dournaud P, Gressens P, Collingridge
GL and Peineau S: The role of JAK-STAT signaling within the CNS.
JAKSTAT. 2:e229252013.PubMed/NCBI
|
|
40
|
Tu Y, Zhong Y, Fu J, Cao Y, Fu G, Tian X
and Wang B: Activation of JAK/STAT signal pathway predicts poor
prognosis of patients with gliomas. Med Oncol. 28:15–23. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zheng Q, Han L, Dong Y, Tian J, Huang W,
Liu Z, Jia X, Jiang T, Zhang J, Li X, et al: JAK2/STAT3 targeted
therapy suppresses tumor invasion via disruption of the
EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in
EGFRvIII-expressing glioblastoma. Neuro Oncol. 16:1229–1243. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhao WJ and Schachner M: Neuregulin 1
enhances cell adhesion molecule l1 expression in human glioma cells
and promotes their migration as a function of malignancy. J
Neuropathol Exp Neurol. 72:244–255. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li J, Liu X, Duan Y, Liu Y, Wang H, Lian
S, Zhuang G and Fan Y: Combined blockade of T cell immunoglobulin
and mucin domain 3 and carcinoembryonic antigen-related cell
adhesion molecule 1 results in durable therapeutic efficacy in mice
with intracranial gliomas. Med Sci Monit. 23:3593–3602. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chen X, Ma WY, Xu SC, Liang Y, Fu YB, Pang
B, Xin T, Fan HT, Zhang R, Luo JG, et al: The overexpression of
epithelial cell adhesion molecule (EpCAM) in glioma. J Neurooncol.
119:39–47. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sloan KE, Stewart JK, Treloar AF, Matthews
RT and Jay DG: CD155/PVR enhances glioma cell dispersal by
regulating adhesion signaling and focal adhesion dynamics. Cancer
Res. 65:10930–10937. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Brösicke N and Faissner A: Role of
tenascins in the ECM of gliomas. Cell Adh Migr. 9:131–140. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Brosicke N, Sallouh M, Prior LM, Job A,
Weberskirch R and Faissner A: Extracellular matrix
glycoprotein-derived synthetic peptides differentially modulate
glioma and sarcoma cell migration. Cell Mol Neurobiol. 35:741–753.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Shimizu T, Kurozumi K, Ishida J, Ichikawa
T and Date I: Adhesion molecules and the extracellular matrix as
drug targets for glioma. Brain Tumor Pathol. 33:97–106. 2016.
View Article : Google Scholar : PubMed/NCBI
|
